Subscribe to RSS
DOI: 10.1055/s-0038-1632929
Bioartificial bone grafting:Tarsal joint fusion in a dog using a bioartificial composite bone graft consisting of β-tricalciumphosphate and platelet rich plasma – A case report
Publication History
Received
12 August 2003
Accepted
05 July 2004
Publication Date:
08 February 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035023/200501/lookinside/thumbnails/10-1055-s-0038-1632929-1.jpg)
Summary
Grafting of large bone defects caused by trauma or tumor resection still remains a problem to solve. In experimental studies as well as in human dentistry, osteoconduction and biodegradation of the β-tricalciumphosphate Cerasorb® as well as osteoinductive capabilities of platelet rich plasma have been proven. In case of luxation of the right tarsal joint, including a compressive fracture of the forth tarsal bone, the recommended use of autologous cancellous bone to support osseous fusion was replaced by the use of a bioartificial bone graft. Biodegradation of the bone graft was proven clinically and radiographically. Complete osseous fusion of the intertarsal joint occurred. The use of the β-tricalciumphosphate Cerasorb in combination with platelet rich plasma to support a partial arthrodesis of the tarsal joint in a dog did not impede the healing process but led to full recovery of the patient, indicating that this concept of bioartificial bone grafting could support bone healing.
-
References
- 1 Sakar M, Bakker FC, Stahl JP, Schnettler R. Biobonein Calciumphosphat-Zement zur Auffüllung knöcherner Defekte. Ergebnisse der klinischen Pilotstudie mit 49 Patienten. Unfallchirurg 1999; 275: 238-9.
- 2 Foitzik C, Stam M. Einsatz von phasenreinem ß-Tricalciumphosphat zur Auffüllung von ossären Defekten-Biologische Materialvorteile und klinische Erfahrungen. Quintessenz 1997; 48: 1365-77.
- 3 Heide H, Karbe E, Kling HG, König R, Köster K, Kramer H. Entwicklung und tierexperimentelle Untersuchungen von implantierbaren, porösen keramischen Werkstoffen. Zwei Teilberichte für das Bundesministerium für Forschung und Technologie. Bonn, Referat III B 3,7 / 12 1973
- 4 Foitzik C, Staus H. Phasenreines ß-Tricalciumphosphat zum Knochenersatz bei parodontaler Indikation. Quintessenz 199 10: 1049-58.
- 5 Marx RE, Carlson ER, Eichstaedt RM, Schimmerle SR, Strauss JE, Georgeff KR. Platelet-rich plasma – Growth factor enhancement for bone grafts. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-46.